INTENDED USE
The 3rd WHO International Standard for hepatitis B virus (HBV), NIBSC code 10/264, is intended to be used in the standardization of nucleic acid amplification technique (NAT)-based assays for HBV. The standard comprises a dilution of the Eurohep reference R1 (genotype A2, HBsAg subtype adw2) [1] , in HBV-negative pooled human plasma. The plasma is also negative for anti-HIV-1; anti-HCV; HCV RNA; and syphilis. The standard has been lyophilized in 0.5 mL aliquots and stored at -20ºC. The material has been calibrated in International Units (IU), in parallel with the 2nd WHO International Standard for HBV, in a collaborative study involving 16 laboratories worldwide [2] .
CAUTION
This preparation is not for administration to humans or animals in the human food chain.
The preparation contains material of human origin, and either the final product or the source materials, from which it is derived, have been tested and found negative for HBsAg, anti-HIV and HCV RNA. As with all materials of biological origin, this preparation should be regarded as potentially hazardous to health. It should be used and discarded according to your own laboratory's safety procedures. Such safety procedures should include the wearing of protective gloves and avoiding the generation of aerosols. Care should be exercised in opening ampoules or vials, to avoid cuts.
UNITAGE
This material has been assigned a unitage of 850,000 IU/mL (~5.93 log10 IU/mL) when reconstituted in 0.5 mL of nuclease-free water.
Uncertainty: the assigned unitage does not carry an uncertainty associated with its calibration. The uncertainty may therefore be considered to be the variance of the vial content and was determined to be +/-1.29%.
CONTENTS
Country of origin of biological material: United Kingdom. Each vial contains 0.5 mL of lyophilized plasma containing infectious HBV.
STORAGE
Vials of lyophilized standard should be stored at -20 °C. Please note: because of the inherent stability of lyophilized material, NIBSC may ship these materials at ambient temperature.
DIRECTIONS FOR OPENING
Vials have a "flip-up" circular cap. Either on the cap or the collar of the vial, there is an indication of the point at which to lever off the cap. This exposes an area of the stopper through which reconstitution and withdrawal of the preparation can be made using a hypodermic needle and syringe. If use of a pipette is preferred, then fully remove the metal collar using, for example, forceps, taking care to avoid cuts by wearing appropriate gloves. Remove the stopper for access. Care should be taken to prevent loss of the contents.
USE OF MATERIAL
No attempt should be made to weigh out any portion of the freeze-dried material prior to reconstitution The material should be reconstituted with 0.5 mL of deionized, nuclease-free molecular-grade water and left for a minimum of 20 minutes with occasional agitation before use. The reconstituted material has a final concentration of 850,000 IU/mL. The International Standard should be used to calibrate secondary reference materials, for example, by determining the equivalent concentration of secondary reference reagent being calibrated, against the International Standard, in parallel. The secondary reference reagent can then be assigned a concentration in terms of the IU. Once reconstituted, the International Standard should be diluted in the matrix appropriate to the material being calibrated, and should be extracted prior to HBV DNA measurement.
STABILITY
Reference materials are held at NIBSC within assured, temperaturecontrolled storage facilities and they should be stored on receipt as indicated on the label. It is the policy of WHO not to assign an expiry date to their international reference materials. Accelerated degradation studies have indicated that this material is suitably stable, when stored at -20 ⁰C, for the assigned values to remain valid until the material is withdrawn or replaced. These studies have also shown that the material is suitably stable for shipment at ambient temperature without any effect on the assigned values. Users who have data supporting any deterioration in the characteristics of any reference preparation are encouraged to contact NIBSC. The stability of the material when reconstituted has not been specifically determined. Therefore, it is recommended that the standard is for single use only.
NIBSC follows the policy of WHO with respect to its reference materials. Contains human plasma and infectious HBV
REFERENCES

Toxicological properties
Effects of inhalation: Avoid, contains infectious HBV Effects of ingestion:
Avoid, contains infectious HBV Effects of skin absorption:
Avoid, contains infectious HBV
Suggested First Aid
Inhalation: Seek medical advice Ingestion:
Seek medical advice Contact with eyes:
Wash with copious amounts of water. Seek medical advice Contact with skin:
Wash thoroughly with water.
Action on Spillage and Method of Disposal
Spillage of ampoule contents should be taken up with absorbent material wetted with an appropriate disinfectant. Rinse area with an appropriate disinfectant followed by water. Absorbent materials used to treat spillage should be treated as biological waste.
LIABILITY AND LOSS
In the event that this document is translated into another language, the English language version shall prevail in the event of any inconsistencies between the documents. Unless expressly stated otherwise by NIBSC, NIBSC"s Standard Terms and Conditions for the Supply of Materials (available at http://www.nibsc.org/About_Us/Terms_and_Conditions.aspx or upon request by the Recipient) ("Conditions") apply to the exclusion of all other terms and are hereby incorporated into this document by reference. The Recipient's attention is drawn in particular to the provisions of clause 11 of the Conditions. 
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